drugset / Trial / NCT07598383

A Multicenter, Randomized, Double-blind, Vehicle Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 Gel in Adult Subjects With Mild to Moderate Atopic Dermatitis

NCT07598383

Phase 2 Recruiting 120 enrolled Jiangsu vcare pharmaceutical technology co., LTD
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a multicenter, randomized, double-blind, vehicle controlled phase II clinical study to evaluate the efficacy and safety of VC005 gel in adult subjects with mild to moderate atopic dermatitis

Timeline

Start
2026-06-01
Primary completion
2027-02-22
Completion
2027-02-22

Drugs

EvaluationDrugModalityDoseRoute
Subject VC005 Unknown Topical

Indications